Clinical Trial Update: The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetic interaction between casopitant and docetaxel in cancer patients; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• casopitant (casopitant)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Nausea and Vomiting, Chemotherapy-Induced | Phase 1 | Status: COMPLETED